Invention Grant
US09073925B2 Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine MCH-1 antagonists, methods of making, and use thereof
有权
氮杂酮取代的氮杂双环链烷基 - 吲哚和氮杂二环烷基 - 吡咯并 - 吡啶MCH-1拮抗剂，其制备方法和用途
- Patent Title: Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine MCH-1 antagonists, methods of making, and use thereof
- Patent Title (中): 氮杂酮取代的氮杂双环链烷基 - 吲哚和氮杂二环烷基 - 吡咯并 - 吡啶MCH-1拮抗剂，其制备方法和用途
-
Application No.: US12828955Application Date: 2010-07-01
-
Publication No.: US09073925B2Publication Date: 2015-07-07
- Inventor: Peter R. Guzzo , Matthew David Surman , Lei Zhu
- Applicant: Peter R. Guzzo , Matthew David Surman , Lei Zhu
- Applicant Address: US NY Albany
- Assignee: Albany Molecular Research, Inc.
- Current Assignee: Albany Molecular Research, Inc.
- Current Assignee Address: US NY Albany
- Agency: LeClairRyan, a Professional Corporation
- Main IPC: A61K31/55
- IPC: A61K31/55 ; C07D487/18 ; C07D487/12 ; C07D487/22 ; C07D471/18 ; C07D471/22
Abstract:
Novel MCH-1 receptor antagonists are disclosed. These compounds are used in the treatment of various disorders, including obesity, anxiety, depression, non-alcoholic fatty liver disease, and psychiatric disorders. Methods of making these compounds are also described in the present invention.
Public/Granted literature
Information query
